DaxibotulinumtoxinA

FDA approves Allergan Aesthetics' Botox Cosmetic for treating moderate to severe vertical platysma bands, offering a nonsurgical option for neck band improvement. Phase III studies showed significant improvement and patient satisfaction. Potential adverse effects include excessive weakness and dysphagia.

FDA approves Botox Cosmetic for platysma bands, marking the first neurotoxin for this use and expanding its aesthetic indications to four.

Botox Cosmetic receives FDA approval for treating moderate to severe vertical neck bands (platysmal bands), marking its first approval beyond facial areas. This new use allows for complete rejuvenation, including the neck, with doses of 26, 31, or 36 units depending on severity. Botox now has four FDA-approved aesthetic uses: forehead lines, frown lines, crow’s feet, and platysmal bands.

Galderma announces phase III READY-4 trial data showing long-term safety of RelabotulinumtoxinA for frown lines and crow’s feet, with efficacy and patient satisfaction maintained across multiple treatments. The study met primary and secondary endpoints, with mild or moderate treatment-emergent adverse events reported by 18% of participants. RelabotulinumtoxinA, developed using PEARL™ Technology, is the first ready-to-use liquid neuromodulator optimized for simple volumetric dosing.

Allergan Aesthetics, an AbbVie company, announced US FDA approval of Botox Cosmetic for temporary improvement in moderate to severe vertical bands connecting the jaw and neck. This marks the fourth aesthetic indication for Botox Cosmetic, expanding its use beyond facial lines. Clinical studies showed significant improvement in platysma band appearance, with 65% and 62% of patients reporting satisfaction 14 days post-treatment.

FDA approves fourth indication for AbbVie's Botox Cosmetic, expanding its use beyond facial wrinkles.

Allergan Aesthetics, an AbbVie company, announces U.S. FDA approval of BOTOX Cosmetic for temporary improvement in moderate to severe vertical platysma bands in adults, expanding its aesthetic indications beyond the face.

Allergan Aesthetics announces FDA approval of Botox Cosmetic for temporary improvement in moderate to severe vertical bands connecting the jaw and neck (platysma bands) in adults, expanding its aesthetic indications beyond the face.

Sidney Bennett, an aesthetic injector and registered nurse, joined Beyond Wellness in June and plans to help expand its services. She enjoys the beauty industry and provides treatments like facial fillers and PRP. Bennett emphasizes continuous learning and networking, aiming to train other nurse injectors. She looks forward to Beyond Wellness opening a Hillcrest location, offering more convenient services to downtown Little Rock.